Drug Bandit Admits to Heists at Lilly, Glaxo Warehouses
Sep 11, 2013
Novo Nordisk, the world's largest insulin maker, is facing a Danish police probe after the company was reported by the Danish Financial Supervisory Authority for not disclosing at once that its new diabetes drug, Tresiba, had been refused U.S. FDA approval.
Savient Pharmaceuticals Inc. plans to sell its drug portfolio, including the gout treatment Krystexxa, to Crealta Pharmaceuticals LLC for $120.4 million, pending bankruptcy court approval.
AbbVie Inc's all-oral hepatitis C therapy cured 96 percent of difficult-to-treat patients in a late-stage clinical trial after 12 weeks.
Almost 2,000 people were vaccinated by the end of the first day
In July 2005, the companies' Dutch subsidiaries entered into a "co-promotion agreement," which delayed the entry of a cheaper generic medicine for 17 months
Alvotech, an Alvogen sister company, is spending $250 million to build a facility in Iceland and manufacture biosimilars.
Proteostasis has entered into a worldwide collaboration with Biogen to develop drugs that could treat certain neurodegenerative disorders, such as Alzheimer’s and Parkinson’s.
Ireland-based QUMAS provides Cloud-based and on-premises enterprise compliance software supporting regulatory and quality operations
The breakthrough therapy has been shown to effectively treat certain types of hepatitis C without the need for interferon.
Takeda announces positive vote on Vedolizumab to treat ulcerative colitis and Crohn's disease